Ratings by
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 3/21/2012 | N/A | Human Genome Sciences | HGSI | Maintain | (N/A) |
10.00 (N/A) |
|
Details | |
| 3/12/2012 | N/A | Amylin Pharmaceuticals | AMLN | Maintain | (N/A) |
12.00 (N/A) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 279 more... | |||||||||
